DTC
KRTX

Deep Track Capital’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Deep Track Capital’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-130,200
Closed -$17.1M – 66
2021
Q4 		$17.1M Buy
+130,200
New +$16.8M 1.2% 33

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Deep Track Capital's KRTX Position: Q1 2022 in Review

Deep Track Capital sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2022, closing a stake of 130,200 shares — an estimated $17.1M sold.

Deep Track Capital first reported a position in KRTX in Q4 2021 and held it in 1 quarter. The position peaked at $17.1M in Q4 2021. 177 funds tracked by Wall St. Rank hold KRTX as of Q1 2022.

  • Deep Track Capital reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Deep Track Capital sold 130,200 Karuna Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $17.1M.
  • Deep Track Capital first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Deep Track Capital's Karuna Therapeutics, Inc. Common Stock position peaked at $17.1M in Q4 2021.
  • 177 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Deep Track Capital's 13F filing for Q1 2022, filed 16 May 2022.